Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Kindly Medical Instruments Co., Ltd. Class H ( (HK:1501) ) just unveiled an update.
Shanghai INT Medical Instruments Co., Ltd. announced a proposed acquisition of a controlling stake in a target company specializing in peripheral vascular interventional medical devices. The target company, established in 2016, has a strong portfolio of innovative products with several patents and NMPA registration certificates. Despite recent financial losses, the target company has shown revenue growth and is valued at RMB500 million, based on market comparisons. This acquisition is expected to enhance Shanghai INT’s market position in the medical device industry.
The most recent analyst rating on (HK:1501) stock is a Buy with a HK$37.00 price target. To see the full list of analyst forecasts on Shanghai Kindly Medical Instruments Co., Ltd. Class H stock, see the HK:1501 Stock Forecast page.
More about Shanghai Kindly Medical Instruments Co., Ltd. Class H
Shanghai INT Medical Instruments Co., Ltd. operates in the medical device industry, focusing on the research, development, production, and sales of peripheral vascular interventional medical devices. The company’s primary products include thoracic aortic stent systems and iliac vein stent systems, with a market focus on innovative medical devices.
Average Trading Volume: 39,540
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$5.61B
Learn more about 1501 stock on TipRanks’ Stock Analysis page.